MetaADEDB 2.0 @ LMMD
ponatinib
(PHXJVRSECIGDHY-UHFFFAOYSA-N)
Structure
SMILES
CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C
Type(s)
Approved; Investigational
ATC code(s)
L01XE24
Molecular Formula:
C29H27F3N6O
Molecular Weight:
532.559
Log P:
4.4048
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
65.77
CAS Number(s):
943319-70-8
Synonym(s)
1.
ponatinib
2.
3-(2-(imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-y-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide
3.
AP 24534
4.
AP-24534
5.
AP24534
6.
Iclusig
7.
ponatinib hydrochloride
External Link(s)
MeSHC545373
PubChem Compound24826799
BindingDB50322535
ChEBI78543
CHEMBLCHEMBL1171837
DrugBankDB08901
DrugCentral4716
IUPHAR/BPS Guide to PHARMACOLOGY5890
KEGGdr:D09950
Therapeutic Target DatabaseD0H0EQ
ZINC36701290
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 256SIDER
US FAERS
2HeadacheFAERS: 217SIDER
US FAERS
3NauseaFAERS: 165SIDER
US FAERS
4Chest PainFAERS: 151
Canada Vigilance: 1
Canada Vigilance
US FAERS
5ConstipationFAERS: 150SIDER
US FAERS
6Dry skinFAERS: 144
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
7ArthralgiaFAERS: 143SIDER
US FAERS
8PainFAERS: 136SIDER
US FAERS
9AstheniaFAERS: 106SIDER
US FAERS
10ThrombocytopeniaFAERS: 104SIDER
US FAERS
11PneumoniaFAERS: 98
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
12Abdominal PainFAERS: 96SIDER
US FAERS
13VomitingFAERS: 90SIDER
US FAERS
14MalaiseFAERS: 88
Canada Vigilance: 1
Canada Vigilance
US FAERS
15Back PainFAERS: 86
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16Blood count abnormalFAERS: 78US FAERS
17White blood cell count decreasedFAERS: 78SIDER
US FAERS
18Cerebrovascular accidentFAERS: 72SIDER
US FAERS
19DizzinessFAERS: 70SIDER
US FAERS
20ChemotherapyFAERS: 66
Canada Vigilance: 2
Canada Vigilance
US FAERS
21InfectionFAERS: 64
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
22MyalgiaFAERS: 63
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
23Stem cell transplantFAERS: 61US FAERS
24AnxietyFAERS: 60US FAERS
25Bone painFAERS: 58SIDER
US FAERS
26PancytopeniaFAERS: 57SIDER
US FAERS
27PancreatitisFAERS: 55
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
28SepsisFAERS: 51
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
29AlopeciaFAERS: 48SIDER
US FAERS
30Chest discomfortFAERS: 48US FAERS
31NeutropeniaFAERS: 48SIDER
US FAERS
32Weight decreasedFAERS: 48SIDER
US FAERS
33Drug ineffectiveFAERS: 46
Canada Vigilance: 3
Canada Vigilance
US FAERS
34Myocardial InfarctionFAERS: 4425304212CTD
SIDER
US FAERS
35Blood glucose increasedFAERS: 41
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
36TransplantFAERS: 39US FAERS
37Febrile NeutropeniaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
38Peripheral swellingFAERS: 38US FAERS
39DehydrationFAERS: 37SIDER
US FAERS
40PruritusFAERS: 34SIDER
US FAERS
41Lipase increasedFAERS: 32SIDER
US FAERS
42Musculoskeletal PainFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
43Disease ProgressionFAERS: 31US FAERS
44Full blood count decreasedFAERS: 31US FAERS
45Night sweatsFAERS: 31SIDER
US FAERS
46Urinary tract infectionFAERS: 31SIDER
US FAERS
47ThrombosisFAERS: 29US FAERS
48EpistaxisFAERS: 28SIDER
US FAERS
49ErythemaFAERS: 28SIDER
US FAERS
50Visual ImpairmentFAERS: 28SIDER
US FAERS
51Acute kidney injuryFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Pericardial effusionFAERS: 26SIDER
US FAERS
53Product use issueFAERS: 26US FAERS
54Pulmonary EmbolismFAERS: 26SIDER
US FAERS
55Joint swellingFAERS: 24US FAERS
56ChillsFAERS: 23
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
57Drug dose omissionFAERS: 23US FAERS
58InfluenzaFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
59NasopharyngitisFAERS: 23
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
60Abdominal discomfortFAERS: 22SIDER
US FAERS
61Alanine Aminotransferase IncreasedFAERS: 22SIDER
US FAERS
62Blood alkaline phosphatase increasedFAERS: 22SIDER
US FAERS
63DyspepsiaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
64Memory impairmentFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
65PallorFAERS: 22US FAERS
66Atrial FibrillationFAERS: 21SIDER
US FAERS
67Neck PainFAERS: 21SIDER
US FAERS
68Rash erythematousFAERS: 21US FAERS
69CellulitisFAERS: 20SIDER
US FAERS
70Peripheral arterial occlusive diseaseFAERS: 20SIDER
US FAERS
71SplenomegalyFAERS: 20US FAERS
72TachycardiaFAERS: 20US FAERS
73Unevaluable eventFAERS: 20US FAERS
74Angina PectorisFAERS: 19SIDER
US FAERS
75BronchitisFAERS: 19US FAERS
76Deep Vein ThrombosisFAERS: 19SIDER
US FAERS
77Erectile dysfunctionFAERS: 19SIDER
US FAERS
78HypothyroidismFAERS: 19US FAERS
79Product dose omissionFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
80SomnolenceFAERS: 19US FAERS
81Clostridium difficile infectionFAERS: 18US FAERS
82CytopeniaFAERS: 18US FAERS
83DysphoniaFAERS: 18SIDER
US FAERS
84No adverse eventFAERS: 18US FAERS
85PalpitationsFAERS: 18US FAERS
86Aspartate Aminotransferase IncreasedFAERS: 17SIDER
US FAERS
87Platelet count abnormalFAERS: 17US FAERS
88Respiratory FailureFAERS: 17US FAERS
89Graft versus host disease in skinFAERS: 16US FAERS
90HypoxiaFAERS: 16US FAERS
91HypotensionFAERS: 15US FAERS
92LymphadenopathyFAERS: 15US FAERS
93Blood creatinine increasedFAERS: 14SIDER
US FAERS
94CataractFAERS: 14US FAERS
95Coronary Artery DiseaseFAERS: 14SIDER
US FAERS
96DiplopiaFAERS: 14US FAERS
97HypersensitivityFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
98NephrolithiasisFAERS: 14US FAERS
99NeuralgiaFAERS: 14US FAERS
100PhotophobiaFAERS: 14US FAERS
101Septic ShockFAERS: 14US FAERS
102Toxicity to various agentsFAERS: 14US FAERS
103UrticariaFAERS: 14US FAERS
104WheezingFAERS: 14US FAERS
105AtelectasisFAERS: 13US FAERS
106Blood potassium decreasedFAERS: 13SIDER
US FAERS
107Burning sensationFAERS: 13US FAERS
108Diabetes MellitusFAERS: 13US FAERS
109Neutrophil count decreasedFAERS: 13SIDER
US FAERS
110Skin WrinklingFAERS: 13US FAERS
111Therapy non-responderFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Transaminases increasedFAERS: 13US FAERS
113Abdominal tendernessFAERS: 12US FAERS
114AphasiaFAERS: 12US FAERS
115ArthritisFAERS: 12US FAERS
116General physical health deteriorationFAERS: 12US FAERS
117Intestinal ObstructionFAERS: 12US FAERS
118Oropharyngeal painFAERS: 12US FAERS
119Skin lesionFAERS: 12US FAERS
120Device related infectionFAERS: 11US FAERS
121Facial paralysisFAERS: 11US FAERS
122LeukocytosisFAERS: 11US FAERS
123Monocyte count increasedFAERS: 11US FAERS
124Oral candidiasisFAERS: 11US FAERS
125StomatitisFAERS: 11SIDER
US FAERS
126AbasiaFAERS: 10US FAERS
127AcneFAERS: 10US FAERS
128Adverse eventFAERS: 10US FAERS
129Cerebral InfarctionFAERS: 10SIDER
US FAERS
130Clostridium difficile colitisFAERS: 10US FAERS
131DeafnessFAERS: 10US FAERS
132Feeling abnormalFAERS: 10US FAERS
133Graft versus host disease in gastrointestinal tractFAERS: 10US FAERS
134Joint stiffnessFAERS: 10US FAERS
135Pulmonary HypertensionFAERS: 10US FAERS
136Skin UlcerFAERS: 10US FAERS
137TremorFAERS: 10US FAERS
138Acute myocardial infarctionFAERS: 9US FAERS
139Amylase increasedFAERS: 9SIDER
US FAERS
140Blood albumin decreasedFAERS: 9SIDER
US FAERS
141Blood chloride increasedFAERS: 9US FAERS
142Blood urea increasedFAERS: 9US FAERS
143Blood urine presentFAERS: 9US FAERS
144Cardiac ArrestFAERS: 9US FAERS
145CholelithiasisFAERS: 9US FAERS
146Drug resistanceFAERS: 9US FAERS
147DysuriaFAERS: 9US FAERS
148Eye painFAERS: 9US FAERS
149GoutFAERS: 9US FAERS
150HepatomegalyFAERS: 9US FAERS
151Iron deficiencyFAERS: 9US FAERS
152PneumonitisFAERS: 9US FAERS
153White blood cell count abnormalFAERS: 9US FAERS
154AscitesFAERS: 8US FAERS
155Blood lactate dehydrogenase increasedFAERS: 8US FAERS
156Gait inabilityFAERS: 8US FAERS
157Graft versus host disease in eyeFAERS: 8US FAERS
158Intentional product misuseFAERS: 8US FAERS
159Peripheral artery stenosisFAERS: 8SIDER
US FAERS
160SunburnFAERS: 8US FAERS
161Urinary IncontinenceFAERS: 8US FAERS
162Urinary RetentionFAERS: 8US FAERS
163Wrong technique in product usage processFAERS: 8US FAERS
164ArteriosclerosisFAERS: 7US FAERS
165BlindnessFAERS: 7US FAERS
166BradycardiaFAERS: 7US FAERS
167Bronchopulmonary AspergillosisFAERS: 7US FAERS
168CardiomegalyFAERS: 7US FAERS
169ColitisFAERS: 7US FAERS
170Depressed moodFAERS: 7US FAERS
171EmbolismFAERS: 7US FAERS
172Exfoliative rashFAERS: 7SIDER
US FAERS
173HepatotoxicityFAERS: 7SIDER
US FAERS
174ImmunosuppressionFAERS: 7US FAERS
175LethargyFAERS: 7SIDER
US FAERS
176LeukopeniaFAERS: 7SIDER
US FAERS
177Limb discomfortFAERS: 7US FAERS
178Musculoskeletal discomfortFAERS: 7SIDER
US FAERS
179Musculoskeletal stiffnessFAERS: 7US FAERS
180PericarditisFAERS: 7US FAERS
181Platelet TransfusionFAERS: 7US FAERS
182SwellingFAERS: 7US FAERS
183Throat irritationFAERS: 7US FAERS
184ThrombocytosisFAERS: 7US FAERS
185Vascular occlusionFAERS: 7SIDER
US FAERS
186Venoocclusive diseaseFAERS: 7US FAERS
187AbscessFAERS: 6US FAERS
188Acute respiratory failureFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
189AmnesiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Anorectal discomfortFAERS: 6US FAERS
191Blood magnesium decreasedFAERS: 6US FAERS
192Blood pressure fluctuationFAERS: 6US FAERS
193Carbon dioxide decreasedFAERS: 6US FAERS
194Cardiac FlutterFAERS: 6US FAERS
195CystitisFAERS: 6US FAERS
196Decreased immune responsivenessFAERS: 6US FAERS
197Dental cariesFAERS: 6US FAERS
198DyschromatopsiaFAERS: 6US FAERS
199DysgeusiaFAERS: 6US FAERS
200EcchymosisFAERS: 6SIDER
US FAERS
201FlatulenceFAERS: 6US FAERS
202Fluid overloadFAERS: 6US FAERS
203GastroenteritisFAERS: 6US FAERS
204Gastrointestinal infectionFAERS: 6US FAERS
205HaematotoxicityFAERS: 6US FAERS
206Hospice CareFAERS: 6US FAERS
207HydronephrosisFAERS: 6US FAERS
208Malignant neoplasm progressionFAERS: 6US FAERS
209MalnutritionFAERS: 6SIDER
US FAERS
210NervousnessFAERS: 6US FAERS
211Neutrophil count abnormalFAERS: 6US FAERS
212ObesityFAERS: 6US FAERS
213PapuleFAERS: 6US FAERS
214Peripheral artery occlusionFAERS: 6US FAERS
215Protein total decreasedFAERS: 6US FAERS
216Respiratory distressFAERS: 6US FAERS
217SciaticaFAERS: 6US FAERS
218SinusitisFAERS: 6US FAERS
219Skin PapillomaFAERS: 6US FAERS
220TinnitusFAERS: 6US FAERS
221VertigoFAERS: 6US FAERS
222Vitamin D DeficiencyFAERS: 6US FAERS
223Vitreous floatersFAERS: 6US FAERS
224treatment failureFAERS: 6US FAERS
225Blood glucose abnormalFAERS: 5US FAERS
226Blood potassium increasedFAERS: 5SIDER
US FAERS
227Cerebral disorderFAERS: 5US FAERS
228ChromaturiaFAERS: 5US FAERS
229DermatitisFAERS: 5SIDER
US FAERS
230Device related thrombosisFAERS: 5US FAERS
231DysarthriaFAERS: 5US FAERS
232Ejection Fraction DecreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
233Eye InfectionFAERS: 5US FAERS
234Eye irritationFAERS: 5US FAERS
235HypophagiaFAERS: 5US FAERS
236Initial insomniaFAERS: 5US FAERS
237Macular degenerationFAERS: 5US FAERS
238MenorrhagiaFAERS: 5US FAERS
239Muscle tightnessFAERS: 5US FAERS
240Musculoskeletal chest painFAERS: 5SIDER
US FAERS
241Pleuritic painFAERS: 5US FAERS
242ProteinuriaFAERS: 5US FAERS
243Renal Artery StenosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
244Retinal DrusenFAERS: 5US FAERS
245Splenic RuptureFAERS: 5US FAERS
246StressFAERS: 5US FAERS
247Thrombosis in deviceFAERS: 5US FAERS
248VIIth nerve paralysisFAERS: 5US FAERS
249Venous ThrombosisFAERS: 5SIDER
US FAERS
250Ventricular hypokinesiaFAERS: 5US FAERS
251AgranulocytosisFAERS: 4US FAERS
252AllodyniaFAERS: 4US FAERS
253Blood cholesterol increasedFAERS: 4US FAERS
254Blood creatine phosphokinase increasedFAERS: 4US FAERS
255Blood glucose decreasedFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
256Brain DeathFAERS: 4US FAERS
257Carpal Tunnel SyndromeFAERS: 4US FAERS
258Complication associated with deviceFAERS: 4US FAERS
259ConjunctivitisFAERS: 4US FAERS
260DementiaFAERS: 4US FAERS
261DemyelinationFAERS: 4US FAERS
262DiscomfortFAERS: 4US FAERS
263DiverticulumFAERS: 4US FAERS
264Erythema NodosumFAERS: 4US FAERS
265Escherichia infectionFAERS: 4US FAERS
266FlushingFAERS: 4SIDER
US FAERS
267Full blood count increasedFAERS: 4US FAERS
268GlaucomaFAERS: 4US FAERS
269HemiparesisFAERS: 4US FAERS
270HepatosplenomegalyFAERS: 4US FAERS
271Hip surgeryFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Homans' sign positiveFAERS: 4US FAERS
273HypersomniaFAERS: 4US FAERS
274HyperthyroidismFAERS: 4US FAERS
275IleusFAERS: 4US FAERS
276Infusion site erythemaFAERS: 4US FAERS
277Intermittent ClaudicationFAERS: 4SIDER
US FAERS
278LichenificationFAERS: 4US FAERS
279Limb injuryFAERS: 4US FAERS
280Lymphocyte count decreasedFAERS: 4US FAERS
281Lymphocyte count increasedFAERS: 4US FAERS
282Mood swingsFAERS: 4US FAERS
283Neutropenic sepsisFAERS: 4US FAERS
284NoduleFAERS: 4US FAERS
285Non-cardiac chest painFAERS: 4SIDER
US FAERS
286Ocular discomfortFAERS: 4US FAERS
287Oncologic complicationFAERS: 4US FAERS
288Optic NeuritisFAERS: 4US FAERS
289OverdoseFAERS: 4US FAERS
290Pancreatic enzymes increasedFAERS: 4US FAERS
291PeritonitisFAERS: 4US FAERS
292Philadelphia chromosome positiveFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
293PleurisyFAERS: 4US FAERS
294Poor peripheral circulationFAERS: 4SIDER
US FAERS
295Pulmonary arterial hypertensionFAERS: 4US FAERS
296RestlessnessFAERS: 4US FAERS
297Retinal Artery OcclusionFAERS: 4US FAERS
298Retinal Vascular DisorderFAERS: 4US FAERS
299Rhinovirus infectionFAERS: 4US FAERS
300Skin toxicityFAERS: 4US FAERS
301Squamous cell carcinomaFAERS: 4US FAERS
302Sudden deathFAERS: 4US FAERS
303Therapy partial responderFAERS: 4US FAERS
304ToothacheFAERS: 4US FAERS
305Wheelchair userFAERS: 4US FAERS
306furuncleFAERS: 4US FAERS
307nervous system disorderFAERS: 4SIDER
US FAERS
308Anaphylactic shockFAERS: 3US FAERS
309AphoniaFAERS: 3US FAERS
310AsthmaFAERS: 3US FAERS
311AtaxiaFAERS: 3US FAERS
312Axillary vein thrombosisFAERS: 3US FAERS
313Back disorderFAERS: 3US FAERS
314BedriddenFAERS: 3US FAERS
315Bladder painFAERS: 3US FAERS
316Blast cell count increasedFAERS: 3US FAERS
317Blood immunoglobulin G decreasedFAERS: 3US FAERS
318Blood iron decreasedFAERS: 3US FAERS
319Blood phosphorus increasedFAERS: 3US FAERS
320Bone lesionFAERS: 3US FAERS
321Brain natriuretic peptide increasedFAERS: 3US FAERS
322BronchospasmFAERS: 3US FAERS
323Cataract operationFAERS: 3US FAERS
324CholangitisFAERS: 3US FAERS
325DeliriumFAERS: 3US FAERS
326DemodicidosisFAERS: 3US FAERS
327Dermatitis acneiformFAERS: 3US FAERS
328Disease susceptibilityFAERS: 3US FAERS
329DisorientationFAERS: 3US FAERS
330EczemaFAERS: 3US FAERS
331Emotional disorderFAERS: 3US FAERS
332Essential HypertensionFAERS: 3US FAERS
333Eyelid skin drynessFAERS: 3US FAERS
334Facial wastingFAERS: 3US FAERS
335Flank PainFAERS: 3US FAERS
336GangreneFAERS: 3US FAERS
337Gastric DilatationFAERS: 3US FAERS
338Gastric ulcerFAERS: 3US FAERS
339Gastrointestinal toxicityFAERS: 3US FAERS
340Graft versus host disease in liverFAERS: 3US FAERS
341Hepatic necrosisFAERS: 3US FAERS
342HungerFAERS: 3US FAERS
343HyperchlorhydriaFAERS: 3US FAERS
344InflammationFAERS: 3US FAERS
345Joint Range of Motion DecreasedFAERS: 3US FAERS
346Limb operationFAERS: 3US FAERS
347Lip neoplasm malignant stage unspecifiedFAERS: 3US FAERS
348Lower respiratory tract infectionFAERS: 3US FAERS
349Maternal exposure during pregnancyFAERS: 3US FAERS
350Medication ErrorFAERS: 3US FAERS
351MeningitisFAERS: 3US FAERS
352Mental status changesFAERS: 3US FAERS
353Miscarriage of partnerFAERS: 3US FAERS
354MyositisFAERS: 3US FAERS
355NocturiaFAERS: 3US FAERS
356Oral mucosal exfoliationFAERS: 3US FAERS
357Pain of skinFAERS: 3SIDER
US FAERS
358Pelvic PainFAERS: 3US FAERS
359Performance status decreasedFAERS: 3US FAERS
360Post lumbar puncture syndromeFAERS: 3US FAERS
361Pregnancy of partnerFAERS: 3US FAERS
362Protein total increasedFAERS: 3US FAERS
363Pulmonary thrombosisFAERS: 3US FAERS
364RalesFAERS: 3US FAERS
365Renal cystFAERS: 3US FAERS
366Rheumatoid ArthritisFAERS: 3US FAERS
367RhinitisFAERS: 3US FAERS
368Rotator cuff syndromeFAERS: 3US FAERS
369Sinus TachycardiaFAERS: 3US FAERS
370Skin reactionFAERS: 3US FAERS
371Splenic InfarctionFAERS: 3SIDER
US FAERS
372UlcerFAERS: 3US FAERS
373UveitisFAERS: 3US FAERS
374jaundiceFAERS: 3SIDER
US FAERS
375Abdominal rigidityFAERS: 2US FAERS
376Acquired gene mutationFAERS: 2US FAERS
377Activities of daily living impairedFAERS: 2US FAERS
378Acute Coronary SyndromeFAERS: 2SIDER
US FAERS
379AgeusiaFAERS: 2US FAERS
380AgitationFAERS: 2US FAERS
381Alanine aminotransferase decreasedFAERS: 2US FAERS
382Anal FissureFAERS: 2US FAERS
383AngioedemaFAERS: 2US FAERS
384Ankle FractureFAERS: 2US FAERS
385Aortic valve sclerosisFAERS: 2US FAERS
386Arterial thrombosisFAERS: 2US FAERS
387ArteritisFAERS: 2US FAERS
388ArthropathyFAERS: 2US FAERS
389Arthropod biteFAERS: 2US FAERS
390AsthenopiaFAERS: 2US FAERS
391Atrial pressure increasedFAERS: 2US FAERS
392Basal cell carcinomaFAERS: 2US FAERS
393Blast cells presentFAERS: 2US FAERS
394Blood 25-hydroxycholecalciferolFAERS: 2US FAERS
395Blood albumin increasedFAERS: 2US FAERS
396Blood alkaline phosphatase abnormalFAERS: 2US FAERS
397Blood bilirubin abnormalFAERS: 2US FAERS
398Blood creatinine decreasedFAERS: 2US FAERS
399Blood lactate dehydrogenase abnormalFAERS: 2US FAERS
400Blood pressure inadequately controlledFAERS: 2US FAERS
401Blood testosterone decreasedFAERS: 2US FAERS
402Blood urea abnormalFAERS: 2US FAERS
403Butterfly rashFAERS: 2US FAERS
404CachexiaFAERS: 2US FAERS
405CardiotoxicityFAERS: 2US FAERS
406Carotid EndarterectomyFAERS: 2US FAERS
407Cell DeathFAERS: 2US FAERS
408Cerebral artery stenosisFAERS: 2SIDER
US FAERS
409Cervix carcinomaFAERS: 2US FAERS
410ChokingFAERS: 2US FAERS
411CholecystitisFAERS: 2US FAERS
412Chronic diseaseFAERS: 2US FAERS
413Chronic graft versus host disease in skinFAERS: 2US FAERS
414ClubbingFAERS: 2US FAERS
415ColectomyFAERS: 2US FAERS
416Contrast media allergyFAERS: 2US FAERS
417Counterfeit product administeredFAERS: 2US FAERS
418Device occlusionFAERS: 2US FAERS
419Device related sepsisFAERS: 2US FAERS
420Diabetes mellitus inadequate controlFAERS: 2US FAERS
421Disease complicationFAERS: 2US FAERS
422DiverticulitisFAERS: 2US FAERS
423Drug administered to patient of inappropriate ageFAERS: 2US FAERS
424Ear discomfortFAERS: 2US FAERS
425Echocardiogram abnormalFAERS: 2US FAERS
426Enterobacter sepsisFAERS: 2US FAERS
427EpilepsyFAERS: 2US FAERS
428EructationFAERS: 2US FAERS
429Escherichia sepsisFAERS: 2US FAERS
430Escherichia test positiveFAERS: 2US FAERS
431Escherichia urinary tract infectionFAERS: 2US FAERS
432Eye excisionFAERS: 2US FAERS
433Eyelid painFAERS: 2US FAERS
434FolliculitisFAERS: 2SIDER
US FAERS
435Foreign body sensation in eyesFAERS: 2US FAERS
436Frustration tolerance decreasedFAERS: 2US FAERS
437Full blood count abnormalFAERS: 2US FAERS
438Fungal test positiveFAERS: 2US FAERS
439Gastric pH decreasedFAERS: 2US FAERS
440GastritisFAERS: 2US FAERS
441Gastrointestinal PainFAERS: 2SIDER
US FAERS
442Gastrointestinal inflammationFAERS: 2US FAERS
443Gastrointestinal sounds abnormalFAERS: 2US FAERS
444Gene MutationFAERS: 2US FAERS
445GingivitisFAERS: 2US FAERS
446Head discomfortFAERS: 2US FAERS
447HemiplegiaFAERS: 2US FAERS
448Hepatic congestionFAERS: 2US FAERS
449Hepatitis CFAERS: 2US FAERS
450HepatitisFAERS: 2US FAERS
451HordeolumFAERS: 2US FAERS
452Human anaplasmosisFAERS: 2US FAERS
453HyperleukocytosisFAERS: 2US FAERS
454Hypertensive crisisFAERS: 2US FAERS
455Impaired self-careFAERS: 2US FAERS
456Incorrect dose administeredFAERS: 2US FAERS
457Insurance issueFAERS: 2US FAERS
458Intentional self-injuryFAERS: 2US FAERS
459Intestinal PerforationFAERS: 2US FAERS
460Intra-abdominal fluid collectionFAERS: 2US FAERS
461Intracranial massFAERS: 2US FAERS
462Iron OverloadFAERS: 2US FAERS
463Keratosis pilarisFAERS: 2US FAERS
464Labile hypertensionFAERS: 2US FAERS
465LabyrinthitisFAERS: 2US FAERS
466Left Ventricular HypertrophyFAERS: 2US FAERS
467Loss of personal independence in daily activitiesFAERS: 2US FAERS
468Low density lipoprotein increasedFAERS: 2US FAERS
469Lower respiratory tract congestionFAERS: 2US FAERS
470Lymph node palpableFAERS: 2US FAERS
471Lymphocyte count abnormalFAERS: 2US FAERS
472LymphomaFAERS: 2US FAERS
473MaculeFAERS: 2US FAERS
474Mental impairmentFAERS: 2US FAERS
475Mesenteric arterial occlusionFAERS: 2US FAERS
476Metastatic NeoplasmFAERS: 2US FAERS
477Myeloblast count decreasedFAERS: 2US FAERS
478MyopathyFAERS: 2US FAERS
479Nasogastric output highFAERS: 2US FAERS
480NephrosclerosisFAERS: 2US FAERS
481Nephrotic SyndromeFAERS: 2US FAERS
482Ocular icterusFAERS: 2US FAERS
483Oral infectionFAERS: 2US FAERS
484Oral painFAERS: 2US FAERS
485OsteopeniaFAERS: 2US FAERS
486OsteoporosisFAERS: 2US FAERS
487Otitis ExternaFAERS: 2US FAERS
488Ovarian adenomaFAERS: 2US FAERS
489OverweightFAERS: 2US FAERS
490PO2 decreasedFAERS: 2US FAERS
491Pancreatic enlargementFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
492Paranasal sinus discomfortFAERS: 2US FAERS
493ParaplegiaFAERS: 2US FAERS
494ParotitisFAERS: 2US FAERS
495Pathological fractureFAERS: 2US FAERS
496Peripheral artery bypassFAERS: 2US FAERS
497Peripheral artery thrombosisFAERS: 2US FAERS
498PetechiaeFAERS: 2SIDER
US FAERS
499PolyneuropathyFAERS: 2US FAERS
500Post procedural complicationFAERS: 2US FAERS
501Posterior reversible encephalopathy syndromeFAERS: 2US FAERS
502PregnancyFAERS: 2US FAERS
503Product packaging quantity issueFAERS: 2US FAERS
504Pulmonary granulomaFAERS: 2US FAERS
505Pulmonary painFAERS: 2US FAERS
506PyelonephritisFAERS: 2US FAERS
507Rash follicularFAERS: 2US FAERS
508Red cell distribution width abnormalFAERS: 2US FAERS
509Red cell distribution width decreasedFAERS: 2US FAERS
510Rehabilitation therapyFAERS: 2US FAERS
511Renal tubular necrosisFAERS: 2US FAERS
512Respiratory fume inhalation disorderFAERS: 2US FAERS
513Restless Legs SyndromeFAERS: 2US FAERS
514Retinal Vein OcclusionFAERS: 2SIDER
US FAERS
515RhonchiFAERS: 2US FAERS
516Sapovirus test positiveFAERS: 2US FAERS
517Secretion dischargeFAERS: 2US FAERS
518SerositisFAERS: 2US FAERS
519Sinus bradycardiaFAERS: 2US FAERS
520Sinus headacheFAERS: 2US FAERS
521Skin irritationFAERS: 2US FAERS
522Slow speechFAERS: 2US FAERS
523SluggishnessFAERS: 2US FAERS
524Suprapubic painFAERS: 2US FAERS
525Terminal stateFAERS: 2US FAERS
526Thermal burnFAERS: 2US FAERS
527Tooth ExtractionFAERS: 2US FAERS
528Tooth InfectionFAERS: 2US FAERS
529Transplantation complicationFAERS: 2US FAERS
530Tumour haemorrhageFAERS: 2US FAERS
531Unresponsive to stimuliFAERS: 2US FAERS
532Urinary hesitationFAERS: 2US FAERS
533Urinary tract obstructionFAERS: 2US FAERS
534Uterine ProlapseFAERS: 2US FAERS
535Vascular stent insertionFAERS: 2US FAERS
536Ventricular drainageFAERS: 2US FAERS
537Vertebral foraminal stenosisFAERS: 2US FAERS
538Vocal Cord DysfunctionFAERS: 2US FAERS
539Wound infection staphylococcalFAERS: 2US FAERS
540skin abrasionFAERS: 2US FAERS
541ABO incompatibilityFAERS: 1US FAERS
542Aborted pregnancyFAERS: 1US FAERS
543Accidental overdoseFAERS: 1US FAERS
544Activated partial thromboplastin time shortenedFAERS: 1US FAERS
545Acute left ventricular failureFAERS: 1US FAERS
546Acute sinusitisFAERS: 1US FAERS
547AdenocarcinomaFAERS: 1US FAERS
548Adjustment disorder with depressed moodFAERS: 1US FAERS
549Altered state of consciousnessFAERS: 1US FAERS
550Ammonia increasedFAERS: 1US FAERS
551Anal abscessFAERS: 1US FAERS
552Anastomotic ulcerFAERS: 1US FAERS
553AngerFAERS: 1US FAERS
554AnuriaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
555Aortic Valve StenosisFAERS: 1US FAERS
556Aortic occlusionFAERS: 1US FAERS
557Aortic wall hypertrophyFAERS: 1US FAERS
558ApathyFAERS: 1US FAERS
559AppendicitisFAERS: 1US FAERS
560Arcus lipoidesFAERS: 1US FAERS
561Aspartate aminotransferase abnormalFAERS: 1US FAERS
562Atypical pneumoniaFAERS: 1US FAERS
563Auricular swellingFAERS: 1US FAERS
564BK virus infectionFAERS: 1US FAERS
565Bacterial sepsisFAERS: 1US FAERS
566Basilar Artery StenosisFAERS: 1US FAERS
567BicytopeniaFAERS: 1US FAERS
568Biliary DyskinesiaFAERS: 1US FAERS
569Bladder wall calcificationFAERS: 1US FAERS
570BlepharitisFAERS: 1US FAERS
571Blood chloride abnormalFAERS: 1US FAERS
572Blood cortisol decreasedFAERS: 1US FAERS
573Blood creatine increasedFAERS: 1US FAERS
574Blood creatinine abnormalFAERS: 1US FAERS
575Blood follicle stimulating hormone increasedFAERS: 1US FAERS
576Blood iron abnormalFAERS: 1US FAERS
577Blood magnesium increasedFAERS: 1US FAERS
578Blood potassium abnormalFAERS: 1US FAERS
579Blood prolactin increasedFAERS: 1US FAERS
580Blood sodium abnormalFAERS: 1US FAERS
581Blood sodium increasedFAERS: 1SIDER
US FAERS
582Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
583Blood thyroid stimulating hormone decreasedFAERS: 1US FAERS
584Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
585Blood triglycerides increasedFAERS: 1SIDER
US FAERS
586Blood urea nitrogen/creatinine ratio decreasedFAERS: 1US FAERS
587Brain stem thrombosisFAERS: 1US FAERS
588Bronchial HyperreactivityFAERS: 1US FAERS
589Burning feet syndromeFAERS: 1US FAERS
590CalcinosisFAERS: 1US FAERS
591Capnocytophaga infectionFAERS: 1US FAERS
592Carbon dioxide abnormalFAERS: 1US FAERS
593Cardiac DeathFAERS: 1US FAERS
594Cardiac TamponadeFAERS: 1US FAERS
595Cardio-respiratory distressFAERS: 1US FAERS
596Cardiovascular insufficiencyFAERS: 1US FAERS
597Carotid artery occlusionFAERS: 1US FAERS
598Catheter site infectionFAERS: 1US FAERS
599Cerebral ArteriosclerosisFAERS: 1US FAERS
600Cerebral ThrombosisFAERS: 1US FAERS
601Cerebral vascular occlusionFAERS: 1US FAERS
602Cerebral vasoconstrictionFAERS: 1US FAERS
603Cerebral ventricle dilatationFAERS: 1US FAERS
604Cervical dysplasiaFAERS: 1US FAERS
605Chemical eye injuryFAERS: 1US FAERS
606CholestasisFAERS: 1US FAERS
607ChromatopsiaFAERS: 1US FAERS
608Cold sweatFAERS: 1US FAERS
609Colon adenomaFAERS: 1US FAERS
610Completed SuicideFAERS: 1US FAERS
611Complications of bone marrow transplantFAERS: 1US FAERS
612Complications of transplant surgeryFAERS: 1US FAERS
613Conjunctival pallorFAERS: 1US FAERS
614Consciousness fluctuatingFAERS: 1US FAERS
615Corneal PerforationFAERS: 1US FAERS
616Coronavirus test positiveFAERS: 1US FAERS
617CryingFAERS: 1US FAERS
618Cystitis viralFAERS: 1US FAERS
619Cytokine Release SyndromeFAERS: 1US FAERS
620Cytomegalovirus test positiveFAERS: 1US FAERS
621Cytotoxic cardiomyopathyFAERS: 1US FAERS
622Depressed Level of ConsciousnessFAERS: 1US FAERS
623Device use issueFAERS: 1US FAERS
624Diabetic foot infectionFAERS: 1US FAERS
625DisabilityFAERS: 1US FAERS
626Donor leukocyte infusionFAERS: 1US FAERS
627Drug abuseFAERS: 1US FAERS
628Drug administration errorFAERS: 1US FAERS
629Drug effect incompleteFAERS: 1US FAERS
630Drug ineffective for unapproved indicationFAERS: 1US FAERS
631Drug prescribing errorFAERS: 1US FAERS
632DyslexiaFAERS: 1US FAERS
633Ear congestionFAERS: 1US FAERS
634Electrocardiogram ST-T changeFAERS: 1US FAERS
635Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
636EnteritisFAERS: 1US FAERS
637Enterococcal infectionFAERS: 1US FAERS
638Enterococcal sepsisFAERS: 1US FAERS
639EnterocolitisFAERS: 1US FAERS
640EnuresisFAERS: 1US FAERS
641EosinophiliaFAERS: 1US FAERS
642Euphoric moodFAERS: 1US FAERS
643Excessive skinFAERS: 1US FAERS
644ExcoriationFAERS: 1US FAERS
645Expired product administeredFAERS: 1US FAERS
646Extra dose administeredFAERS: 1US FAERS
647Extremity necrosisFAERS: 1US FAERS
648Eye allergyFAERS: 1US FAERS
649Facial ParesisFAERS: 1US FAERS
650Failure to ThriveFAERS: 1US FAERS
651Feeling ColdFAERS: 1US FAERS
652Fibrin D dimer increasedFAERS: 1US FAERS
653FibrosisFAERS: 1US FAERS
654Food PoisoningFAERS: 1US FAERS
655Gamma-Glutamyltransferase IncreasedFAERS: 1SIDER
US FAERS
656Gastric infectionFAERS: 1US FAERS
657GastrostomyFAERS: 1US FAERS
658General symptomFAERS: 1US FAERS
659Graft versus host disease in intestineFAERS: 1US FAERS
660Graft versus host disease in lungFAERS: 1US FAERS
661Groin infectionFAERS: 1US FAERS
662Growth retardationFAERS: 1US FAERS
663Guillain-Barre SyndromeFAERS: 1US FAERS
664Heart sounds abnormalFAERS: 1US FAERS
665Hepatic EncephalopathyFAERS: 1US FAERS
666Hepatitis BFAERS: 1US FAERS
667Hepatosplenic candidiasisFAERS: 1US FAERS
668HerniaFAERS: 1US FAERS
669Histiocytosis haematophagicFAERS: 1US FAERS
670Human rhinovirus test positiveFAERS: 1US FAERS
671HydrocephalusFAERS: 1US FAERS
672HyperkeratosisFAERS: 1US FAERS
673HyperparathyroidismFAERS: 1US FAERS
674Hypertensive emergencyFAERS: 1US FAERS
675HypogonadismFAERS: 1US FAERS
676HypokinesiaFAERS: 1US FAERS
677HyporeflexiaFAERS: 1US FAERS
678Immune thrombocytopenic purpuraFAERS: 1US FAERS
679ImpatienceFAERS: 1US FAERS
680Implantable defibrillator insertionFAERS: 1US FAERS
681Inappropriate schedule of drug administrationFAERS: 1US FAERS
682Inappropriate schedule of product administrationFAERS: 1US FAERS
683Incision site infectionFAERS: 1US FAERS
684IncontinenceFAERS: 1US FAERS
685IndurationFAERS: 1US FAERS
686Infection reactivationFAERS: 1US FAERS
687Infusion site thrombosisFAERS: 1US FAERS
688Injection site painFAERS: 1US FAERS
689Intervertebral disc disorderFAERS: 1US FAERS
690KeratitisFAERS: 1US FAERS
691KeratorhexisFAERS: 1US FAERS
692LaryngitisFAERS: 1US FAERS
693Left atrial dilatationFAERS: 1US FAERS
694Limb girth decreasedFAERS: 1US FAERS
695Limb massFAERS: 1US FAERS
696Lip swellingFAERS: 1US FAERS
697Liver function test decreasedFAERS: 1US FAERS
698Lobar PneumoniaFAERS: 1US FAERS
699Localised intraabdominal fluid collectionFAERS: 1US FAERS
700Lower respiratory tract infection bacterialFAERS: 1US FAERS
701LymphadenitisFAERS: 1US FAERS
702Lymphocyte percentage increasedFAERS: 1US FAERS
703Malabsorption from administration siteFAERS: 1US FAERS
704MalariaFAERS: 1US FAERS
705MastitisFAERS: 1US FAERS
706Mechanical ventilationFAERS: 1US FAERS
707Mesenteric artery stenosisFAERS: 1US FAERS
708MetamorphopsiaFAERS: 1US FAERS
709MetastasisFAERS: 1US FAERS
710Middle insomniaFAERS: 1US FAERS
711Monocyte count decreasedFAERS: 1US FAERS
712MucormycosisFAERS: 1US FAERS
713MultimorbidityFAERS: 1US FAERS
714Multiple SclerosisFAERS: 1US FAERS
715Myocardial fibrosisFAERS: 1US FAERS
716MyocarditisFAERS: 1US FAERS
717Nasal mucosal disorderFAERS: 1US FAERS
718NecrosisFAERS: 1US FAERS
719NephrectomyFAERS: 1US FAERS
720Nerve injuryFAERS: 1US FAERS
721NeuromaFAERS: 1US FAERS
722Non-high-density lipoprotein cholesterol increasedFAERS: 1US FAERS
723Occult blood positiveFAERS: 1US FAERS
724Oropharyngeal discomfortFAERS: 1US FAERS
725OsteomyelitisFAERS: 1US FAERS
726Pancreatic NeoplasmFAERS: 1US FAERS
727Pancreatic carcinomaFAERS: 1US FAERS
728PanniculitisFAERS: 1US FAERS
729Paranasal sinus hypersecretionFAERS: 1US FAERS
730Paternal exposure timing unspecifiedFAERS: 1US FAERS
731Penile burning sensationFAERS: 1US FAERS
732Peripheral artery angioplastyFAERS: 1US FAERS
733Peripheral embolismFAERS: 1US FAERS
734PhlebitisFAERS: 1US FAERS
735Pneumonia moraxellaFAERS: 1US FAERS
736PolydipsiaFAERS: 1US FAERS
737Poor dental conditionFAERS: 1US FAERS
738Poor quality sleepFAERS: 1US FAERS
739Post procedural bile leakFAERS: 1US FAERS
740Post procedural infectionFAERS: 1US FAERS
741Post stroke seizureFAERS: 1US FAERS
742Post-Traumatic Stress DisorderFAERS: 1US FAERS
743Pre-existing condition improvedFAERS: 1US FAERS
744Procedural complicationFAERS: 1US FAERS
745Product packaging issueFAERS: 1US FAERS
746Product solubility abnormalFAERS: 1US FAERS
747Product taste abnormalFAERS: 1US FAERS
748Product use in unapproved indicationFAERS: 1US FAERS
749Productive CoughFAERS: 1US FAERS
750Protein total abnormalFAERS: 1US FAERS
751Psychomotor skills impairedFAERS: 1US FAERS
752Pulmonary congestionFAERS: 1US FAERS
753Pulmonary interstitial emphysema syndromeFAERS: 1US FAERS
754Pulmonary sepsisFAERS: 1US FAERS
755PyuriaFAERS: 1US FAERS
756Quality of life decreasedFAERS: 1US FAERS
757Radiation injuryFAERS: 1US FAERS
758Radiation necrosisFAERS: 1US FAERS
759RadiculopathyFAERS: 1US FAERS
760Rash maculovesicularFAERS: 1US FAERS
761Renal artery occlusionFAERS: 1US FAERS
762Renal massFAERS: 1US FAERS
763Renal painFAERS: 1US FAERS
764Respiratory arrestFAERS: 1US FAERS
765Respiratory tract congestionFAERS: 1US FAERS
766Respiratory tract infection bacterialFAERS: 1US FAERS
767Retinal vascular thrombosisFAERS: 1US FAERS
768Right Ventricular HypertrophyFAERS: 1US FAERS
769Right ventricular systolic pressure increasedFAERS: 1US FAERS
770Salivary gland painFAERS: 1US FAERS
771SchistocytosisFAERS: 1US FAERS
772Sensory level abnormalFAERS: 1US FAERS
773Sexual DysfunctionFAERS: 1US FAERS
774ShockFAERS: 1US FAERS
775Skin tightnessFAERS: 1US FAERS
776SnoringFAERS: 1US FAERS
777Spleen palpableFAERS: 1US FAERS
778Splenic abscessFAERS: 1US FAERS
779SpondylitisFAERS: 1US FAERS
780StenosisFAERS: 1US FAERS
781Suicide attemptFAERS: 1US FAERS
782Supraventricular tachycardiaFAERS: 1US FAERS
783SyncopeFAERS: 1US FAERS
784Systemic mycosisFAERS: 1US FAERS
785Therapeutic procedureFAERS: 1US FAERS
786Therapeutic product effect incompleteFAERS: 1US FAERS
787Therapy cessationFAERS: 1US FAERS
788ThirstFAERS: 1US FAERS
789ThoracostomyFAERS: 1US FAERS
790ThrombophlebitisFAERS: 1US FAERS
791Thrombotic strokeFAERS: 1US FAERS
792ThyroplastyFAERS: 1US FAERS
793Tooth LossFAERS: 1US FAERS
794TracheomalaciaFAERS: 1US FAERS
795Tracheostomy malfunctionFAERS: 1US FAERS
796Transfusion ReactionFAERS: 1US FAERS
797Transplant evaluationFAERS: 1US FAERS
798Traumatic fractureFAERS: 1US FAERS
799TrismusFAERS: 1US FAERS
800TuberculosisFAERS: 1US FAERS
801Upper-airway cough syndromeFAERS: 1US FAERS
802Urethritis noninfectiveFAERS: 1US FAERS
803Urine flow decreasedFAERS: 1US FAERS
804Vaginal DischargeFAERS: 1US FAERS
805Vascular resistance systemic increasedFAERS: 1US FAERS
806Vascular stent occlusionFAERS: 1US FAERS
807Vascular stent restenosisFAERS: 1US FAERS
808Vascular stent stenosisFAERS: 1US FAERS
809VasculitisFAERS: 1US FAERS
810Venous stenosisFAERS: 1US FAERS
811Venous thrombosis limbFAERS: 1US FAERS
812Ventricular FibrillationFAERS: 1US FAERS
813Ventricular hypertrophyFAERS: 1US FAERS
814Vertebral Artery StenosisFAERS: 1US FAERS
815Viral upper respiratory tract infectionFAERS: 1US FAERS
816Vulvovaginal adhesionFAERS: 1US FAERS
817Vulvovaginal painFAERS: 1US FAERS
818White matter lesionFAERS: 1US FAERS
819Wrong doseFAERS: 1US FAERS
820Wrong technique in drug usage processFAERS: 1US FAERS
821XerosisFAERS: 1US FAERS
822keratoacanthomaFAERS: 1US FAERS
823kyphosisFAERS: 1US FAERS
824prostatitisFAERS: 1US FAERS
825Amylase decreasedSIDER
826Atrial FlutterSIDER
827Blood amylase increasedSIDER
828Blood and lymphatic system disordersSIDER
829Blood phosphorus decreasedSIDER
830Ca++ increasedSIDER
831Calcium lowSIDER
832Cardiac discomfortSIDER
833Creatinine increasedSIDER
834Glucose decreasedSIDER
835Glucose increasedSIDER
836Heart failure25304212CTD
837InfestationSIDER
838LymphopeniaSIDER
839MyelosuppressionSIDER
840Neoplasms, Experimental

View details

CTD
841NeuropathySIDER
842Ocular ToxicitySIDER
843Phosphorus lowSIDER
844Potassium increasedSIDER
845Potassium lowSIDER
846PrurigoSIDER
847Sodium decreasedSIDER
848Sodium highSIDER
849Venous ThromboembolismSIDER
850effusionSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.